Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synflorix Immunogenicity in Children with Sickle Cell Disease
NCT01175083Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2011
- Primary completion
- Jan 2013
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal disease, sponsored by GSK. Started Jun 2011; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT01175083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01175083.